Overview
Fellowship: Duke University, Hematology & Medical Oncology (2021-2025)
Residency: University of Miami / Jackson Memorial Hospital (2018-2021)
Medical/Graduate: Medical University of South Carolina (2008-2018)
Doctor of Medicine, May 2018
Doctor of Philosophy in Microbiology & Immunology, May 2018
Undergraduate: University of South Carolina (2004-2008)
Bachelor of Science, Chemical Engineering
Bachelor of Science, Biological Sciences
Minor in Medical Humanities
Residency: University of Miami / Jackson Memorial Hospital (2018-2021)
Medical/Graduate: Medical University of South Carolina (2008-2018)
Doctor of Medicine, May 2018
Doctor of Philosophy in Microbiology & Immunology, May 2018
Undergraduate: University of South Carolina (2004-2008)
Bachelor of Science, Chemical Engineering
Bachelor of Science, Biological Sciences
Minor in Medical Humanities
Current Appointments & Affiliations
Medical Instructor in the Department of Medicine
·
2025 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2025 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
CaMKK2 Identifies Biologically Aggressive Chronic Lymphocytic Leukemia and Regulates Leukemic Survival and Nurse-Like Cell Support
Preprint · February 24, 2026 Full text CiteGenomic classifiers and prognosis of localized prostate cancer: a systematic review.
Journal Article Prostate Cancer Prostatic Dis · March 2025 BACKGROUND: Refinement of the risk classification for localized prostate cancer is warranted to aid in clinical decision making. A systematic analysis was undertaken to evaluate the prognostic ability of three genomic classifiers, Decipher, GPS, and Prolar ... Full text Link to item CiteImpact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review.
Journal Article Ann Intern Med · February 2025 BACKGROUND: Tissue-based genomic classifiers (GCs) have been developed to improve prostate cancer (PCa) risk assessment and treatment recommendations. PURPOSE: To summarize the impact of the Decipher, Oncotype DX Genomic Prostate Score (GPS), and Prolaris ... Full text Link to item CiteRecent Grants
The Role of the DNA Sensor AIM2 in B Cell Fate and Function After HCT
ResearchPI-Fellow · Awarded by Leukemia & Lymphoma Society · 2024 - 2026View All Grants
Education
Medical University of South Carolina ·
2018
M.D.
University of South Carolina, Columbia ·
2008
B.S.